Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Twst crawled time : 13:30 save search
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 7, 2024
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: -1.08%
H: 1.07%
C: -4.38%
nasdaq corporation bioscience grants
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
Published: 2024-02-02 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 14.25%
H: 0.11%
C: -3.71%
first bioscience financial results
Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 6.74%
H: 0.25%
C: -5.91%
drug bioscience
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 6.74%
H: 0.25%
C: -5.91%
antibody bioscience agreement
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
Published: 2023-10-03 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: -0.99%
H: 2.27%
C: -3.21%
bioscience
Twist Bioscience Becomes Digital Preservation Coalition Supporter
Published: 2022-02-28 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 0.0%
H: 6.15%
C: 1.75%
bioscience
Twist Bioscience Reports First Quarter 2022 Financial Results
Published: 2022-02-04 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 2.81%
H: 0.0%
C: 0.0%
financial results report bioscience results
Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics
Published: 2022-01-25 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: -2.04%
H: 1.61%
C: -2.76%
therapeutics cel collaboration bioscience
Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022
Published: 2022-01-20 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: -3.44%
H: 4.18%
C: -4.94%
financial results report bioscience results
At 17.42% CAGR, Oligonucleotide Synthesis Market Size is Expected to Reach USD 22584.1 Million in 2028, says Brandessence Market Research
Published: 2022-01-17 (Crawled : 13:30) - prnewswire.com
SRPT | $118.385 -3.65% -3.79% 770K
|
Health Technology
| Email alert
Add to watchlist
DHR | $239.66 -0.12% 0.0% 2.7M
|
Health Technology
| Email alert
Add to watchlist
ALNY | $147.775 -0.49% -0.49% 490K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $196.76 -0.72% -0.72% 1.2M
|
Health Technology
| Email alert
Add to watchlist
IONS | $41.56 -0.43% -0.43% 760K
|
Health Technology
| Email alert
Add to watchlist
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
| Email alert
Add to watchlist
ce mark leo research
Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research
Published: 2022-01-06 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: -5.46%
H: 5.86%
C: 1.31%
genomic research bioscience
Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants
Published: 2022-01-05 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: -9.17%
H: 0.0%
C: 0.0%
rbt-0813 therapeutics sars-cov-2 bioscience iot
Twist Bioscience Launches 96-Plex Library Prep Kit for Low Pass High Throughput Next-Generation Sequencing
Published: 2021-12-20 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 10.79%
H: 0.0%
C: -2.94%
bioscience
Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs
Published: 2021-11-18 (Crawled : 13:30) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 1.92%
H: 2.07%
C: -4.33%
disease partnership antibody
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.